Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Swirsky Insider Profile
4 Followers
Douglas Swirsky, President & CEO, Director at GenVec Inc, holds 25.00K shares in Cellectar Biosciences (Ticker: CLRB), holds 50.00K shares in Ocuphire Pharma (Ticker: OCUP), holds 242.50K shares in GenVec Inc (Ticker: GNVC). Most recently, Douglas Swirsky Bought ― shares of Cellectar Biosciences on Sep 14, 2021 for an estimated value of 26.00K.
Douglas Swirsky GenVec Inc (GNVC)President & CEO, Director
GenVec Inc (GNVC)
President & CEO, Director
Ranked #92,052 out of 98,501 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-70.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Douglas Swirsky holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 14, 2021 - Sep 14, 2022
Return:-56.00%
The most profitable trade made by Douglas Swirsky
Douglas Swirsky's Trading History
GenVec Inc
Jun 20, 2017
―
Uninformative Sell
―
$1.74M
Cellectar Biosciences
Sep 14, 2021
Director
Informative Buy
26.00K
$80.25K
Pernix Therapeutics
―
―
―
―
Ocuphire Pharma
Jan 30, 2019
President & CEO, Director
Informative Buy
31.50K
$87.00K
NeuroBo Pharmaceuticals
―
Director
―
―
Fibrocell Science
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Douglas Swirsky's performance on stock
You May Also Like
Douglas Swirsky insider profile FAQ
What is the percentage of profitable transactions made by Douglas Swirsky?
The percentage of profitable transactions made by Douglas Swirsky is 0%.
What is the average return per transaction made by Douglas Swirsky?
The average return per transaction made by Douglas Swirsky is -70.80%.
What stocks does Douglas Swirsky hold?
Douglas Swirsky holds: GNVC, CLRB, PTXTQ, OCUP, NRBO, FCSC stocks.
What was Douglas Swirsky’s latest transaction?
Douglas Swirsky latest transaction was an Informative Buy of $26.00K.
What was Douglas Swirsky's most profitable transaction?
Douglas Swirsky’s most profitable transaction was an Informative Buy of CLRB stock on September 14, 2021. The return on the trade was -56.00%.
What is Douglas Swirsky's role in GenVec Inc?
Douglas Swirsky's role in GenVec Inc is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.